Bihag, Floramie B.
HRN: 17-03-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
COTRIMOXAZOLE 960MG (TAB)
04/10/2025
04/17/2025
PO
960mg
BID
Acute Uncomplicated Pyelonephritis
Waiting Final Action
Indication: Culture-directed Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes